200.21MMarket Cap-1569P/E (TTM)
5.620High5.260Low282.80KVolume5.390Open5.460Pre Close1.56MTurnover1.45%Turnover RatioLossP/E (Static)35.94MShares23.03052wk High1.48P/B108.34MFloat Cap3.61052wk Low--Dividend TTM19.45MShs Float43.690Historical High--Div YieldTTM6.59%Amplitude2.840Historical Low5.508Avg Price1Lot Size
Biomea Fusion Stock Forum
The pause on clinical trials seems to be a result of the explosion of industry regulations in recent years. From 2022 through 2024, the FDA has implemented "additional steps" to clinical trials, including bringing in outside agencies to help with oversight.
Red tape and bureaucracy, not BEMA, caused this pause. All the research I've done shows the pause was premature and overly cautious.
No comment yet